Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb2
|
ENSMUSG00000075588.5 | homeobox B2 |
Dlx2
|
ENSMUSG00000023391.7 | distal-less homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_71629066_71629667 | Dlx2 | 82612 | 0.060773 | 0.55 | 6.0e-06 | Click! |
chr2_71545291_71545476 | Dlx2 | 567 | 0.686706 | 0.49 | 7.2e-05 | Click! |
chr2_71543869_71545172 | Dlx2 | 1430 | 0.329014 | 0.48 | 1.3e-04 | Click! |
chr2_71613195_71613430 | Dlx2 | 66558 | 0.079334 | 0.44 | 3.7e-04 | Click! |
chr2_71543552_71543703 | Dlx2 | 2323 | 0.218339 | 0.42 | 8.0e-04 | Click! |
chr11_96351942_96352391 | Hoxb2 | 535 | 0.541889 | -0.21 | 1.0e-01 | Click! |
chr11_96351044_96351195 | Hoxb2 | 512 | 0.563709 | 0.21 | 1.1e-01 | Click! |
chr11_96352529_96353688 | Hoxb2 | 1477 | 0.177020 | -0.17 | 2.0e-01 | Click! |
chr11_96351294_96351445 | Hoxb2 | 262 | 0.795465 | 0.16 | 2.2e-01 | Click! |
chr11_96350827_96350978 | Hoxb2 | 377 | 0.683797 | 0.10 | 4.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_52700044_52701597 | 14.20 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr9_41585694_41587243 | 13.37 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr18_23036665_23037864 | 11.64 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr3_4796861_4798079 | 10.34 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr6_55678280_55679200 | 10.14 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr8_45508499_45509041 | 10.04 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr2_6881042_6881689 | 9.70 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr15_30458403_30458947 | 9.46 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
887 |
0.67 |
chr11_36676450_36677161 | 8.88 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr2_57613916_57615034 | 8.79 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr8_12398370_12398923 | 8.59 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chrX_153501207_153502250 | 8.58 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr1_77505286_77506951 | 8.54 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr17_51760240_51761547 | 8.43 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chr18_43686487_43688415 | 8.33 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr14_64592977_64593388 | 8.02 |
Mir3078 |
microRNA 3078 |
1997 |
0.25 |
chr2_6881874_6882908 | 7.98 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr12_107990188_107992301 | 7.93 |
Bcl11b |
B cell leukemia/lymphoma 11B |
12170 |
0.28 |
chr4_97582473_97584218 | 7.93 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr15_25415436_25415919 | 7.78 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr8_109248831_109249717 | 7.78 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr8_54954519_54955779 | 7.70 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr4_54950838_54951442 | 7.66 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr1_81077232_81078427 | 7.64 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chrX_133682515_133683917 | 7.52 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr12_89815214_89815490 | 7.42 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr1_42259362_42260538 | 7.38 |
Gm28175 |
predicted gene 28175 |
1905 |
0.34 |
chr10_110454344_110454630 | 7.35 |
Nav3 |
neuron navigator 3 |
1717 |
0.42 |
chr2_105675959_105678109 | 7.33 |
Pax6 |
paired box 6 |
905 |
0.54 |
chr13_83724063_83724214 | 7.32 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2757 |
0.18 |
chr2_18042311_18043883 | 7.27 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr12_46816152_46816702 | 7.20 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr2_181763361_181764530 | 7.19 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr13_44842150_44842855 | 7.18 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr16_77236514_77236677 | 7.02 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
276 |
0.93 |
chr7_78885666_78887958 | 6.99 |
Mir7-2 |
microRNA 7-2 |
1465 |
0.28 |
chr3_34652462_34653573 | 6.94 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr10_29143400_29144848 | 6.91 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr2_32428080_32429746 | 6.88 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr8_45507516_45508498 | 6.81 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr1_173389412_173390669 | 6.80 |
Cadm3 |
cell adhesion molecule 3 |
22345 |
0.14 |
chr5_131615202_131615755 | 6.77 |
2810432F15Rik |
RIKEN cDNA 2810432F15 gene |
40 |
0.94 |
chr11_34315414_34316667 | 6.76 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr10_92160735_92161461 | 6.76 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
1663 |
0.4 |
chr3_79144294_79146166 | 6.74 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr13_83715222_83716973 | 6.73 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr2_102661017_102661704 | 6.68 |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
2079 |
0.37 |
chr7_79501250_79502506 | 6.58 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr4_82915737_82916950 | 6.52 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
1909 |
0.38 |
chr9_91360032_91360505 | 6.48 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2145 |
0.17 |
chr3_66746318_66747483 | 6.46 |
Gm6555 |
predicted gene 6555 |
135450 |
0.05 |
chr5_98182267_98183697 | 6.41 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr12_71048832_71049275 | 6.38 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
712 |
0.65 |
chr9_74977325_74977617 | 6.36 |
Fam214a |
family with sequence similarity 214, member A |
1360 |
0.45 |
chr16_43504464_43505047 | 6.33 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr18_59062200_59063436 | 6.31 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr3_67892808_67893503 | 6.27 |
Iqschfp |
Iqcj and Schip1 fusion protein |
923 |
0.42 |
chr1_109984209_109985108 | 6.25 |
Cdh7 |
cadherin 7, type 2 |
921 |
0.74 |
chr4_110285249_110285423 | 6.21 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr2_140668225_140669392 | 6.16 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2592 |
0.43 |
chr11_94045498_94046076 | 6.15 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr8_41054476_41055299 | 6.13 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr16_77596529_77597235 | 6.09 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1980 |
0.16 |
chr13_14520339_14520490 | 6.05 |
Gm30893 |
predicted gene, 30893 |
1072 |
0.37 |
chr12_49387532_49388566 | 5.94 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr3_5224377_5225076 | 5.91 |
Zfhx4 |
zinc finger homeodomain 4 |
3221 |
0.24 |
chr17_90452868_90453681 | 5.86 |
Nrxn1 |
neurexin I |
1548 |
0.36 |
chr10_111247804_111248910 | 5.86 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr7_92234907_92236280 | 5.85 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr15_92598307_92599654 | 5.82 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr13_73117045_73117937 | 5.81 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115904 |
0.06 |
chr10_57784547_57786586 | 5.79 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr8_14382368_14383445 | 5.79 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr18_37217058_37218378 | 5.76 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr1_177444257_177446079 | 5.75 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr1_194621653_194621902 | 5.74 |
Plxna2 |
plexin A2 |
1952 |
0.34 |
chr2_181766837_181767244 | 5.61 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr13_83739310_83740387 | 5.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr16_77594640_77595970 | 5.60 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr6_32584464_32585789 | 5.57 |
Plxna4 |
plexin A4 |
3066 |
0.3 |
chr2_77701567_77703605 | 5.55 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr18_69500231_69501482 | 5.53 |
Tcf4 |
transcription factor 4 |
20 |
0.99 |
chr15_78118149_78118442 | 5.52 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
1411 |
0.31 |
chr2_80126598_80127760 | 5.52 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
1655 |
0.42 |
chr3_45384939_45386122 | 5.48 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr13_112289274_112289896 | 5.40 |
Ankrd55 |
ankyrin repeat domain 55 |
765 |
0.56 |
chr1_66386919_66387899 | 5.39 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr2_65620767_65621991 | 5.38 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr3_67892003_67892637 | 5.32 |
Iqschfp |
Iqcj and Schip1 fusion protein |
88 |
0.51 |
chr14_93883900_93884713 | 5.31 |
Pcdh9 |
protocadherin 9 |
1442 |
0.55 |
chr4_55928799_55929534 | 5.30 |
Gm12519 |
predicted gene 12519 |
64573 |
0.14 |
chr4_23602363_23602952 | 5.29 |
Gm25978 |
predicted gene, 25978 |
24088 |
0.22 |
chr3_134330789_134331989 | 5.29 |
Gm43558 |
predicted gene 43558 |
25903 |
0.15 |
chr9_41587250_41587725 | 5.28 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr5_116312100_116312726 | 5.27 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
53 |
0.96 |
chr4_5724213_5725550 | 5.27 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr8_34890130_34891317 | 5.26 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr12_29534253_29535510 | 5.25 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr18_31446492_31447667 | 5.24 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr16_91320391_91321321 | 5.23 |
Gm15966 |
predicted gene 15966 |
4884 |
0.15 |
chr6_143259703_143261097 | 5.22 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
14507 |
0.2 |
chr6_96113911_96115198 | 5.21 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr13_99443316_99444666 | 5.21 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr6_15188050_15189424 | 5.14 |
Foxp2 |
forkhead box P2 |
3174 |
0.4 |
chr16_16558986_16560577 | 5.13 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr17_11664263_11665109 | 5.12 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr8_108536302_108537095 | 5.11 |
Gm39244 |
predicted gene, 39244 |
249 |
0.95 |
chr3_154816919_154817899 | 5.09 |
Gm18589 |
predicted gene, 18589 |
22198 |
0.2 |
chrX_110811626_110812334 | 5.09 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chr12_88725972_88726370 | 5.06 |
Nrxn3 |
neurexin III |
490 |
0.84 |
chr14_76420544_76421824 | 5.05 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr8_96455054_96456367 | 5.04 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr3_88208231_88208654 | 5.02 |
Gm3764 |
predicted gene 3764 |
1030 |
0.28 |
chrX_49272929_49273965 | 5.01 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
14765 |
0.24 |
chr4_24429570_24429771 | 4.99 |
Gm27243 |
predicted gene 27243 |
1220 |
0.52 |
chr13_78196283_78196791 | 4.98 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr13_83735558_83735982 | 4.98 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chrX_105390628_105392456 | 4.96 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr16_77420100_77420782 | 4.95 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
1379 |
0.28 |
chr8_90345047_90345661 | 4.95 |
Tox3 |
TOX high mobility group box family member 3 |
2772 |
0.42 |
chr3_88210550_88210701 | 4.95 |
Gm3764 |
predicted gene 3764 |
1153 |
0.24 |
chr16_63863108_63864179 | 4.94 |
Epha3 |
Eph receptor A3 |
230 |
0.96 |
chr11_80480761_80480912 | 4.94 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
3780 |
0.22 |
chr9_41377643_41378358 | 4.93 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chr18_81509510_81510030 | 4.90 |
Gm50412 |
predicted gene, 50412 |
29413 |
0.19 |
chr19_38348426_38349048 | 4.90 |
Gm50150 |
predicted gene, 50150 |
6123 |
0.16 |
chr13_44946654_44947258 | 4.88 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr13_83736071_83736534 | 4.87 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr13_83732205_83734272 | 4.83 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr18_25749825_25750329 | 4.83 |
Celf4 |
CUGBP, Elav-like family member 4 |
2615 |
0.33 |
chr2_65932868_65933620 | 4.82 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1379 |
0.47 |
chr3_118430889_118431675 | 4.82 |
Gm26871 |
predicted gene, 26871 |
958 |
0.44 |
chr1_19215607_19218714 | 4.80 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr6_13835523_13837039 | 4.79 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr1_66324716_66324867 | 4.79 |
Map2 |
microtubule-associated protein 2 |
2689 |
0.25 |
chr1_6729327_6730832 | 4.77 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr10_29145584_29145749 | 4.77 |
Gm9996 |
predicted gene 9996 |
1472 |
0.31 |
chr10_90577565_90578158 | 4.77 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr11_69834618_69835201 | 4.77 |
Nlgn2 |
neuroligin 2 |
60 |
0.9 |
chr4_13747506_13748460 | 4.76 |
Runx1t1 |
RUNX1 translocation partner 1 |
3314 |
0.37 |
chr2_53501543_53502209 | 4.76 |
Gm13503 |
predicted gene 13503 |
50050 |
0.17 |
chr2_38340293_38341511 | 4.75 |
Lhx2 |
LIM homeobox protein 2 |
190 |
0.93 |
chr3_34653590_34654523 | 4.75 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr17_85394123_85395241 | 4.73 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
103951 |
0.07 |
chr13_34125172_34126139 | 4.72 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr9_52148115_52149635 | 4.71 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr1_168426195_168428871 | 4.71 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr1_177446374_177448525 | 4.70 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr8_123410787_123412789 | 4.70 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr12_29528407_29529244 | 4.70 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr18_80984086_80984990 | 4.68 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr16_78313182_78314564 | 4.68 |
Cxadr |
coxsackie virus and adenovirus receptor |
11334 |
0.15 |
chr14_100374663_100375528 | 4.66 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr8_22012864_22013642 | 4.66 |
Ccdc70 |
coiled-coil domain containing 70 |
42657 |
0.08 |
chr18_25750468_25751272 | 4.66 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr7_29071185_29072068 | 4.65 |
Gm26604 |
predicted gene, 26604 |
11 |
0.87 |
chr7_79512487_79513145 | 4.64 |
2900037B21Rik |
RIKEN cDNA 2900037B21 gene |
108 |
0.91 |
chr6_16727216_16727889 | 4.64 |
Gm36669 |
predicted gene, 36669 |
49972 |
0.17 |
chrX_6169933_6171264 | 4.64 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr17_62659451_62660256 | 4.63 |
Gm25800 |
predicted gene, 25800 |
202733 |
0.03 |
chr7_126950022_126951260 | 4.63 |
Sez6l2 |
seizure related 6 homolog like 2 |
57 |
0.89 |
chr11_94044930_94045437 | 4.63 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr13_97248475_97250229 | 4.63 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr4_6986587_6987701 | 4.63 |
Tox |
thymocyte selection-associated high mobility group box |
3339 |
0.35 |
chr14_75963198_75963625 | 4.63 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
8402 |
0.18 |
chr17_90088736_90088977 | 4.62 |
Nrxn1 |
neurexin I |
456 |
0.9 |
chr4_125492765_125493053 | 4.59 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
2209 |
0.31 |
chr5_120426818_120428597 | 4.59 |
Lhx5 |
LIM homeobox protein 5 |
3992 |
0.15 |
chr8_49462071_49462635 | 4.59 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
970 |
0.52 |
chr12_108000728_108001440 | 4.57 |
Bcl11b |
B cell leukemia/lymphoma 11B |
2330 |
0.41 |
chr6_55680133_55680881 | 4.56 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr4_25797578_25797990 | 4.55 |
Fut9 |
fucosyltransferase 9 |
2071 |
0.32 |
chr3_134236641_134237783 | 4.54 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr14_60380755_60381381 | 4.52 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr4_24429141_24429555 | 4.51 |
Gm27243 |
predicted gene 27243 |
1542 |
0.44 |
chr17_17402413_17403374 | 4.50 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chrX_58033180_58034063 | 4.49 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr10_92161472_92161916 | 4.49 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
1067 |
0.55 |
chr13_83718912_83719403 | 4.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2224 |
0.22 |
chr18_81165961_81166641 | 4.49 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chrX_23283125_23283785 | 4.47 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr7_79503072_79503475 | 4.47 |
Mir9-3 |
microRNA 9-3 |
1991 |
0.16 |
chr18_22345719_22346098 | 4.47 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
819 |
0.78 |
chr14_22037484_22037938 | 4.46 |
Gm7480 |
predicted gene 7480 |
1608 |
0.33 |
chr8_88813002_88813481 | 4.46 |
Rps6-ps2 |
ribosomal protein S6, pseudogene 2 |
6850 |
0.22 |
chr1_138346039_138346510 | 4.45 |
Gm28500 |
predicted gene 28500 |
30990 |
0.17 |
chr9_41582824_41584205 | 4.45 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr9_61376232_61377980 | 4.44 |
Tle3 |
transducin-like enhancer of split 3 |
1577 |
0.38 |
chrX_84076569_84077653 | 4.43 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chrX_110812404_110812672 | 4.41 |
Gm44593 |
predicted gene 44593 |
214 |
0.93 |
chr10_18741812_18742086 | 4.39 |
Gm32926 |
predicted gene, 32926 |
1520 |
0.33 |
chr13_28881136_28881895 | 4.37 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr11_108607202_108607707 | 4.35 |
Cep112 |
centrosomal protein 112 |
2227 |
0.37 |
chr1_137902800_137903236 | 4.35 |
Gm4258 |
predicted gene 4258 |
4420 |
0.1 |
chr5_107497766_107498034 | 4.34 |
Btbd8 |
BTB (POZ) domain containing 8 |
121 |
0.94 |
chr13_99446279_99447668 | 4.33 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr13_8205494_8206737 | 4.32 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr2_72426765_72427714 | 4.32 |
Cdca7 |
cell division cycle associated 7 |
48920 |
0.13 |
chr18_35212708_35213458 | 4.30 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr7_62416059_62417205 | 4.29 |
Mkrn3 |
makorin, ring finger protein, 3 |
3507 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.1 | 12.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.1 | 12.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.1 | 21.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.7 | 5.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.6 | 13.2 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
2.6 | 20.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.5 | 5.0 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
2.5 | 17.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.3 | 9.2 | GO:0060594 | mammary gland specification(GO:0060594) |
2.3 | 13.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.2 | 11.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.2 | 8.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.2 | 6.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.1 | 6.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.1 | 8.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.1 | 6.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.1 | 8.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.1 | 24.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.1 | 8.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.0 | 8.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.0 | 8.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.0 | 2.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.0 | 3.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.9 | 5.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.9 | 7.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.7 | 12.1 | GO:0097264 | self proteolysis(GO:0097264) |
1.7 | 13.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.6 | 4.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.6 | 1.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.5 | 6.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.5 | 6.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.5 | 3.0 | GO:0021586 | pons maturation(GO:0021586) |
1.5 | 4.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.5 | 14.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.4 | 7.2 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.4 | 2.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.4 | 8.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.4 | 10.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 4.3 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.4 | 2.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.4 | 7.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.4 | 5.5 | GO:0030035 | microspike assembly(GO:0030035) |
1.3 | 1.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.3 | 14.7 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.3 | 2.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.3 | 11.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.3 | 6.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.3 | 3.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 5.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 1.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 3.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 5.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.2 | 18.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.2 | 1.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
1.2 | 7.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.2 | 3.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.2 | 2.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.2 | 2.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.2 | 2.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.1 | 5.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.1 | 10.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.1 | 5.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.1 | 3.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.1 | 4.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.1 | 8.7 | GO:0060074 | synapse maturation(GO:0060074) |
1.1 | 4.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.1 | 18.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.1 | 4.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 4.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 5.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.0 | 3.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.0 | 5.0 | GO:0060023 | soft palate development(GO:0060023) |
1.0 | 4.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 3.9 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.0 | 2.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 4.8 | GO:0072017 | distal tubule development(GO:0072017) |
0.9 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 1.9 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.9 | 2.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 5.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 2.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.9 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 8.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.9 | 6.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.9 | 3.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.9 | 7.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.9 | 3.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.9 | 3.5 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 2.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.9 | 11.5 | GO:0001964 | startle response(GO:0001964) |
0.9 | 1.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 3.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 2.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.8 | 3.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.8 | 2.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.8 | 4.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.8 | 4.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 0.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.8 | 1.7 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.8 | 2.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.8 | 4.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.8 | 1.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 6.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 2.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.8 | 2.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.8 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 1.6 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.8 | 4.8 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 3.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.8 | 2.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.8 | 2.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 3.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 2.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 1.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.7 | 38.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 2.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 2.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 2.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.7 | 1.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.7 | 2.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 2.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 2.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 2.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 4.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 0.7 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.7 | 0.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.7 | 6.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.7 | 2.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.7 | 2.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.7 | 2.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.7 | 3.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.6 | 1.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 1.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 1.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.6 | 1.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 2.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 46.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 13.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 2.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 1.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.2 | GO:1904395 | positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 1.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.6 | 15.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.6 | 2.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 3.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 1.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 3.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 2.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 1.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 5.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 4.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 1.9 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.5 | 4.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 2.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 1.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 1.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 2.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.4 | 2.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 5.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 0.8 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.4 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 3.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 0.8 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.4 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.4 | 1.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 2.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 5.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 3.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 7.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 3.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.4 | 1.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 1.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 1.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.4 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 0.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.4 | 2.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 1.5 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 10.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 3.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.4 | 0.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 2.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.1 | GO:0021794 | thalamus development(GO:0021794) |
0.4 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 5.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 2.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 2.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 2.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 8.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 3.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 21.8 | GO:0050808 | synapse organization(GO:0050808) |
0.3 | 6.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.6 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 0.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 0.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 24.9 | GO:0007411 | axon guidance(GO:0007411) |
0.3 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 0.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.3 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 1.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 2.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 2.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 2.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 2.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 2.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 4.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 1.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 2.3 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.2 | 0.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 1.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.4 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 2.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.9 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.2 | 1.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 2.8 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 9.0 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.2 | 0.2 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.2 | 0.4 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 1.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 2.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 8.9 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.2 | 2.0 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 0.2 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.2 | 0.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 1.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.2 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 4.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.2 | 0.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.3 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.9 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 4.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.2 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.1 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.3 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.3 | GO:0007442 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 1.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 5.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 8.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 2.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 1.0 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.3 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.8 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 5.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.5 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 8.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 2.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.2 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 1.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.3 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.1 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.6 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 1.0 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.5 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 1.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.6 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 2.7 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.2 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0032511 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.8 | 14.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.5 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 13.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 8.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 33.7 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 3.6 | GO:0072534 | perineuronal net(GO:0072534) |
1.2 | 4.7 | GO:1990696 | USH2 complex(GO:1990696) |
1.2 | 6.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 56.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 5.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 10.4 | GO:0030673 | axolemma(GO:0030673) |
1.0 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 4.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 13.9 | GO:0043196 | varicosity(GO:0043196) |
1.0 | 17.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 12.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.8 | 5.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 2.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 5.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.7 | 6.4 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 7.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 8.2 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 10.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 5.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 91.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 2.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 3.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 15.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 5.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 4.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 37.5 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 4.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 2.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 8.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 6.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 4.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 30.7 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 3.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 16.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 1.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 2.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 23.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 3.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 8.9 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.8 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 22.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 4.0 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 3.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 3.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 0.3 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 2.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 4.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 23.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.8 | 14.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.8 | 23.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.7 | 9.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.4 | 12.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.4 | 7.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.4 | 16.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.4 | 21.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.0 | 5.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 5.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.7 | 12.0 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 6.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.4 | 8.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.3 | 7.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 9.2 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 14.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.2 | 3.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.2 | 4.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 4.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 4.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 7.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.0 | 1.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.0 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 4.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.0 | 1.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 7.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.9 | 5.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 2.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.9 | 2.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 4.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 4.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 18.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 3.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 8.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 18.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 5.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 1.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 2.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 2.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 2.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 1.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 3.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 3.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 3.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 5.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 3.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 1.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 14.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 14.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.6 | 1.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 6.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 3.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 2.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 3.7 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 5.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.5 | 7.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 2.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 8.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 12.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 8.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 2.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 6.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 1.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.4 | 1.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 10.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 2.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 2.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 15.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 7.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 13.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 3.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 0.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 4.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 2.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 3.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 5.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 4.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 2.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 2.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 2.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 5.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.3 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 2.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 6.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 3.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 3.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 4.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 5.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 3.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 5.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.2 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 4.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 3.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 4.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 4.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 2.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 2.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 4.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 4.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 3.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 7.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 1.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0034870 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 4.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.2 | GO:0018575 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 4.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 9.5 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 1.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 2.4 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 27.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 1.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 21.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 14.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 16.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 10.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 8.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 32.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 6.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 1.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 3.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 8.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 4.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 5.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 7.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 2.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 5.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 5.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 33.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.1 | 8.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 13.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.0 | 17.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 17.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 13.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 11.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 7.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 6.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 11.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 2.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 3.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 5.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 5.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 11.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 5.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 4.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 7.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 3.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 5.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 3.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 5.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 5.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 4.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 9.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 3.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 5.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 4.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 8.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 2.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 6.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 3.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 3.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 9.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 2.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |